[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575291":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":40,"centralContacts":51,"locations":58,"responsibleParty":83,"collaborators":87,"id":93,"slug":40,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":94,"sex":100,"minAge":101,"maxAge":40,"enrollmentInfo":102,"targetDuration":40,"studyType":105,"phases":106,"briefSummary":108,"conditions":109,"keywords":114,"overallStatus":61,"whyStopped":40,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":130},{"fullName":5,"class":6},"Hospital Arnau de Vilanova","OTHER",[8,17],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","ACTIVE_COMPARATOR","After cannulation of a midline or peripherally inserted central venous catheter with modified micro-Seldinger technique, the control group underwent standard care.",[13,14,15,16],"Procedure: Control group: acrylic adhesive sutureless fixation device","Device: PICC","Device: Midline","Other: Ultrasound scanner",{"label":18,"type":19,"description":20,"interventionNames":21},"Intervention","EXPERIMENTAL","After cannulation of a midline or peripherally inserted central venous catheter with modified micro-Seldinger technique, the intervention group underwent the alternative care.",[22,14,15,16],"Procedure: Intervention Group: zinc oxide sutureless fixation device",[24,30,35,41,45],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"PROCEDURE","Control group: acrylic adhesive sutureless fixation device","The standard care consists of:\n\n* Application of hemostasis at the point of insertion for 2 minutes post puncture or until bleeding stops.\n* Fix with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and acrylic adhesive sutureless fixation device (3300MWA Grip-Lok®).",[9],[9],{"type":25,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"Intervention Group: zinc oxide sutureless fixation device","Alternative care consisted of:\n\n* Application of haemostasis at the insertion site for 2 minutes post-puncture or until cessation of bleeding.\n* Fixation with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and zinc oxide sutureless fixation device (2200NUZA Grip-Lok®).",[18],[18],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":40},"DEVICE","PICC","The PICC lines used in the study will all be third-generation polyurethane and of the commercial brands:\n\n* PowerPICC™ 4, 5 and 6 Fr from BD\n* Maxflo expert™ 5 and 6 Fr from Vygon",[9,18],null,{"type":36,"name":42,"description":43,"armGroupLabels":44,"otherNames":40},"Midline","The midline lines used in the study will be second or third generation polyurethane and of the commercial brands:\n\n* PowerMidline™ 4 Fr from BD\n* Arrow® Midline 4Fr from Arrow",[9,18],{"type":6,"name":46,"description":47,"armGroupLabels":48,"otherNames":49},"Ultrasound scanner","All punctures will be performed under ultrasound guidance.",[9,18],[50],"Ultrasound",[52],{"name":53,"role":54,"phone":55,"phoneExt":56,"email":57},"Padilla-Nula F PhD candidate, Nurse","CONTACT","+ 34 973 24 81 00","8 4169","FPADILLA@gencat.cat",[59,76],{"facility":60,"status":61,"city":62,"state":63,"zip":64,"country":65,"cosmosGeoPoint":66,"geoPoint":71,"contacts":72},"Arnau de Vilanova Hospital","RECRUITING","Lleida","Catalonia","25001","Spain",{"type":67,"coordinates":68},"Point",[69,70],0.62218,41.61674,{"lat":70,"lon":69},[73],{"name":74,"role":54,"phone":75,"phoneExt":40,"email":57},"Padilla-Nula F, Nursing graduat","973 24 81 00",{"facility":77,"status":78,"city":62,"state":63,"zip":79,"country":65,"cosmosGeoPoint":80,"geoPoint":82,"contacts":40},"Hospital Universitari Arnau de Vilanova","COMPLETED","25198",{"type":67,"coordinates":81},[69,70],{"lat":70,"lon":69},{"type":84,"investigatorFullName":85,"investigatorTitle":86,"investigatorAffiliation":5,"oldNameTitle":40,"oldOrganization":40},"PRINCIPAL_INVESTIGATOR","Ferran Padilla Nula","Principal Investigator",[88,91],{"name":89,"class":90},"Official College of Nurses of Lleida","UNKNOWN",{"name":92,"class":90},"Department of Health, Generalitat de Catalunya (PERIS)","100575291",false,"NCT06770374","Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients","Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients: Randomised Clinical Trial","FIX-ETI","Inclusion Criteria:\n\n* requiring cannulation of a midline catheter or a PICC\n* who accepted and signed the informed consent voluntarily\n* with an inpatient unit admission of minimum 7 days\n\nExclusion Criteria:\n\n\\- patients with a known allergy to zinc oxide","ALL","18 Years",{"count":103,"type":104},400,"ESTIMATED","INTERVENTIONAL",[107],"NA","Study in which a zinc oxide fixation device (a product that can help protect the skin) for catheters (polyurethane tubes inserted into a vein) will be tested to reduce catheter-related complications: catheter displacement, skin complications, phlebitis and pain..",[110,111,112,113],"Vascular Access Complication","Skin and Subcutaneous Tissue Disorders","Phlebitis","Pain",[115,116,117,118,119,120],"Catheters","Vascular Access Devices","Catheter-Related Infections","Nurse Specialists","Nurses","Randomised Controlled Trial","2026-04-02",{"date":123,"type":124},"2026-04-08","ACTUAL",{"date":126,"type":124},"2025-02-01",{"date":128,"type":104},"2026-12-31",{"name":5,"class":6},2]